Nantahala Capital Management Q3 2026 Investment Activity

According to filings reviewed via InsiderSet, Nantahala Capital Management, LLC demonstrated significant buying and selling activity during the third quarter of 2026.

Significant Purchases This Quarter

Nantahala Capital Management has been actively investing in several companies this quarter:

• Avalo Therapeutics (AVTX): The firm increased its stake by 50.79%, acquiring an additional 627,250 shares.
• Fulcrum Therapeutics (FULC): Nantahala Capital Management purchased a substantial amount of stock, increasing holdings by 79.51% or 2,425,000 shares.
• Aldurai Biotherapeutics (ADMA): The investor quintupled its position with a 100% increase in shares held during the quarter.
• Mimedx Group (MDXG): Nantahala Capital Management boosted its stake by approximately 40.33%, adding over one million shares.

These purchases, particularly those exceeding a 50% increase in allocation like AVTX and FULC, suggest strong conviction in these companies' potential during this period of portfolio rebalancing.

Notable Sales This Quarter

In contrast to its buying activity, Nantahala Capital Management also divested significant portions of its holdings:

• Peloton Interactive (PTON): The largest sale by the fund this quarter occurred in Consumer Cyclical stocks. PTON saw a 57.43% reduction in shares held, representing nearly an entire position liquidated.

While other significant sales like TLSI (-51.71%) and BRCC (-52.21%) are also noted as disclosed by the firm via InsiderSet, specific details for other exits (ESTA, TNGX) were not available in this filing.

For further details on the investor or specific stock companies mentioned, you can explore Nantahala Capital Management and individual stocks like AVTX, FULC, or MDXG on the InsiderSet platform.